Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/09/2010CN101723939A Isopentenyl-oxyl substituted dehydrogenized silybin ether and preparation method and application thereof
06/09/2010CN101723938A Synthesis processes and bioactivities of 3-aromatic (hetero)-6,8-dyhydroxy isoflavonoid compounds
06/09/2010CN101723900A Cinnamide compound
06/09/2010CN101723896A Tyrosine derivative histone deacetylases inhibitor and application thereof
06/09/2010CN101723878A Preparation method of donepezil
06/09/2010CN101723844A Agomelatine crystal form B, preparation method thereof and medicinal composition containing same
06/09/2010CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
06/09/2010CN101721705A Sleep-easy preparation- efficient endogenous physiological regulating control agent
06/09/2010CN101721690A Application of PTD-SOD fusion protein in anti-intoxication alcohol neutralizing product
06/09/2010CN101721669A Traditional Chinese medicine composition for treating cold dampness type sciatica
06/09/2010CN101721668A Medicine for treating headache
06/09/2010CN101721664A Traditional Chinese medicine for treating apoplectic hemiplegia and general paralysis
06/09/2010CN101721635A Method for preparing medicinal physiotherapy compound health-care medicament core
06/09/2010CN101721623A Traditional Chinese medicine for treating trigeminal neuralgia
06/09/2010CN101721622A Traditional Chinese medicine for treating tension-type headache
06/09/2010CN101721621A Headache treating liquid
06/09/2010CN101721619A Externally-applied traditional Chinese medicine composition for treating brain stem tumors and preparation method thereof
06/09/2010CN101721600A Medicine for treating neurasthenia
06/09/2010CN101721571A Chinese herbal medicine footherapy fragrant flower
06/09/2010CN101721570A Method for extracting acorus calamus human body massage liquid
06/09/2010CN101721567A Grassleaf sweetflag rhizome extract, preparation method and application thereof
06/09/2010CN101721566A Traditional Chinese medicine wine for treating sciatica
06/09/2010CN101721539A Traditional Chinese medicine sachet and preparation method thereof
06/09/2010CN101721538A Health-care cigarette prepared from rhiizoma dioscoreae from Henan of China and chrysanthemum and used for reinforcing immunological function
06/09/2010CN101721511A Medicine combination for treating headache or migraine and preparation method thereof
06/09/2010CN101721510A Medicine composition for treating headache or migraine and preparation method thereof
06/09/2010CN101721486A Eye guard for treating insomnia and preparation method thereof
06/09/2010CN101721468A Method for preparing salvianolic acids
06/09/2010CN101721442A Method for preparing ginseng soaked by rice vinegar
06/09/2010CN101721439A Notoginseng leaf triterpenes capsule and preparation thereof
06/09/2010CN101721433A Double-mushroom polysaccharide preparation containing flammulina velutipes polysaccharide and lentinan polysaccharide and preparation method and application thereof
06/09/2010CN101721429A Application of amniotic epithelial cells and cell preparations thereof
06/09/2010CN101721420A Antishock function of ginsenoside Re
06/09/2010CN101721419A Application of 1,6-diphosphofructose phosphatase for preventing and treating parkinsonism
06/09/2010CN101721416A Huperzine A solid composition and preparation method thereof
06/09/2010CN101721396A Application of resveratrol in preparing medicament for treating tristimania
06/09/2010CN101721086A Method for manufacturing silkworm sand pillow
06/09/2010CN101289448B Method for preparing 1,3,7,9-tetramethyl uric acid
06/09/2010CN101278924B Meclofenoxate hydrochloride microcapsule and method for preparing injection thereof
06/09/2010CN101229351B Medicine compounds with detoxication uses
06/09/2010CN101219220B Remifentanil polymer sustained-release analgesic and its preparing process
06/09/2010CN101176773B Plaster for curing neurotic facial palsy and preparation method thereof
06/09/2010CN101167912B Medicine for treating spastic cerebral paralysis disease and its preparing method
06/09/2010CN101130029B Orally taken medicament for treating affective psychosis
06/09/2010CN101119989B Chroman derivatives and uses thereof in treating CNS disease
06/09/2010CN101095886B Chinese traditional medicine for treating heart neurosis and method for preparing the same
06/09/2010CN101029051B (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the AMPA receptor
06/09/2010CN100998666B Oral traditional Chinese medicine for treating trifacial neuralgia of cold-condensing and blood-stasis type
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732488 Marine oil derived ethyl ester of eicosapentaenoic acid and docosahexaenoic acid, with specified reduced levels of brominated flame retardants; not a health supplement; treat hypertriglyceridaemia
06/08/2010US7732487 Administering calcium channel modulators such as 13,14-dihydro 15-keto-16,16-difluoroprostaglandin E1, for prophylaxis of brain, cardiovascular, gastrointerstinal, respiratory system, vision or liver disorders
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732463 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders
06/08/2010US7732462 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732447 such as 4-Pyridin-3-yl-2,5-dihydro-pyridazino[4,5-b]indol-1-one, used as inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase, mixed lineage kinase (MLK) or cyclin-dependent kinase (CDK); treatment of angiogenic disorders and neurodegenerative diseases
06/08/2010US7732438 CGRP receptor antagonists
06/08/2010US7732413 1,4-Diphenyl-3-substituted azetidin-2-ones; can be metabolized in vivo to form a sterol and/or stanol absorption inhibitor and a sterol biosynthesis inhibitor for treatment of atherosclerosis, hypercholesterolemia, or sitosterolemia
06/08/2010US7732407 Method for treatment of demyelinating central nervous system disease
06/08/2010US7732201 neural cells comprising a neuroblast and a nestin-positive neural cell; for treating neuronal disorders
06/08/2010US7732200 Using chondroitin sulfate proteoglycan (CSPG)-degrading enzymes mixture to propagate nervous system tissue in culture for use as tissue targeted tools in treatment of brain and neurodegenerative disorders
06/08/2010US7732149 Methods of screening agonistic antibodies
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7731989 Gastric retained gabapentin dosage form
06/08/2010CA2440553C 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2433453C Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
06/08/2010CA2433039C Agent for therapeutic and prophylactic treatment of neuropathic pain
06/08/2010CA2416442C Substituted 5-alkynyl pyrimidines having neurotrophic activity
06/08/2010CA2389300C 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
06/08/2010CA2386547C Orally disintegrating composition comprising mirtazapine
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/03/2010WO2010062900A2 A new family of pain producing substances and methods to produce novel analgesic drugs
06/03/2010WO2010062692A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010062690A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
06/03/2010WO2010062681A2 Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
06/03/2010WO2010062570A2 COMPOSITIONS COMPRISING CAPTURE PEPTIDES FOR A β-AMYLOID PEPTIDE
06/03/2010WO2010062565A1 Muscarinic agonists
06/03/2010WO2010062559A1 Substituted pyrazoloquinolines and derivatives thereof
06/03/2010WO2010062399A2 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010WO2010062245A1 Spirocyclobutyl piperidine derivatives
06/03/2010WO2010062206A1 Choline salts of succinic acid for the treatment of depression, anxiety, schizophrenia, sleep disorder, and epilepsy
06/03/2010WO2010062136A2 Composition for mitochondrial activation
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061931A1 Cyclobutyl purine derivative, angiogenesis promoting agent, lumenization promoting agent, neurocyte growth promoting agent, and drug
06/03/2010WO2010061899A1 Transformed soybean plant which stores vaccine, and use thereof
06/03/2010WO2010061574A1 Sleep-improving agent, sedative agent, and use thereof
06/03/2010WO2010061474A1 Connecting magnetic element, connecting magnetic element manufacturing method, connecting magnetic element injecting device, connecting magnetic element injection control system, magnetic field control device, and connecting magnetic element injection control method
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010061074A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010WO2010060955A1 Novel 2-morpholino-3-amido-pyridine derivatives and their medical use
06/03/2010WO2010060952A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
06/03/2010WO2010060852A1 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/03/2010WO2010060742A1 Combination of bifeprunox and an antipsychotic drug with d2/5-ht2a receptor antagonistic activity for treating cns disorders
06/03/2010WO2010060589A1 Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
06/03/2010WO2010060472A1 Imidazopyridazine derivatives acting as orexin antagonists
06/03/2010WO2010060471A1 Piperidine derivatives useful as orexin receptor antagonists
06/03/2010WO2010060470A1 Piperidine derivatives useful as orexin receptor antagonists
06/03/2010WO2010060190A1 Plant extract compositions for affecting sleep
06/03/2010WO2010036773A8 Deuterated 1-aryl-2 -aminomethyl cyclopropane carboxyamide derivatives
1 ... 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 ... 1833